Hill-Rom Holdings Inc. (NYSE:HRC) saw unusually-high trading volume on Friday . Approximately 745,377 shares changed hands during mid-day trading, an increase of 29% from the previous session’s volume of 575,847 shares.The stock last traded at $59.04 and had previously closed at $58.44.

HRC has been the subject of a number of research analyst reports. Zacks Investment Research raised shares of Hill-Rom Holdings from a “hold” rating to a “buy” rating and set a $64.00 price target for the company in a report on Tuesday, August 9th. KeyCorp reaffirmed a “buy” rating and issued a $59.00 price target on shares of Hill-Rom Holdings in a report on Thursday, June 23rd. Bank of America Corp. reaffirmed a “buy” rating and issued a $69.00 price target on shares of Hill-Rom Holdings in a report on Monday, May 2nd. Finally, Morgan Stanley reaffirmed a “hold” rating on shares of Hill-Rom Holdings in a report on Tuesday, May 3rd. One research analyst has rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. The stock presently has an average rating of “Buy” and an average price target of $61.50.

The stock has a 50-day moving average of $54.64 and a 200 day moving average of $50.59. The firm has a market capitalization of $3.88 billion and a PE ratio of 61.03.

Hill-Rom Holdings (NYSE:HRC) last announced its earnings results on Thursday, August 4th. The medical technology company reported $0.81 earnings per share for the quarter, topping the consensus estimate of $0.76 by $0.05. During the same period in the previous year, the company earned $0.62 earnings per share. The business had revenue of $655.40 million for the quarter, compared to analysts’ expectations of $647.75 million. Hill-Rom Holdings’s quarterly revenue was up 38.1% on a year-over-year basis. Equities analysts forecast that Hill-Rom Holdings Inc. will post $3.33 EPS for the current year.

A hedge fund recently bought a new stake in Hill-Rom Holdings stock. Marshall Wace LLP bought a new stake in Hill-Rom Holdings Inc. (NYSE:HRC) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund bought 34,840 shares of the medical technology company’s stock, valued at approximately $1,674,000. Marshall Wace LLP owned approximately 0.05% of Hill-Rom Holdings as of its most recent SEC filing.

Hill-Rom Holdings, Inc is a medical technology company. The Company offers patient care solutions that improve clinical and economic outcomes in advancing mobility, wound care and prevention, clinical workflow, surgical safety and efficiency, and respiratory health areas. Its segments include North America, Surgical and Respiratory Care, International and Welch Allyn.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.